- Home
- ZEPP vs LVTX Comparison
ZEPP vs LVTX Comparison
Compare ZEPP & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEPP
- LVTX
- Stock Information
- Founded
- ZEPP 2013
- LVTX 2016
- Country
- ZEPP China
- LVTX Netherlands
- Employees
- ZEPP N/A
- LVTX N/A
- Industry
- ZEPP Computer Manufacturing
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ZEPP Technology
- LVTX Health Care
- Exchange
- ZEPP Nasdaq
- LVTX Nasdaq
- Market Cap
- ZEPP 48.8M
- LVTX 25.3M
- IPO Year
- ZEPP N/A
- LVTX 2021
- Fundamental
- Price
- ZEPP $2.80
- LVTX $1.03
- Analyst Decision
- ZEPP
- LVTX Buy
- Analyst Count
- ZEPP 0
- LVTX 3
- Target Price
- ZEPP N/A
- LVTX $3.33
- AVG Volume (30 Days)
- ZEPP 11.1K
- LVTX 169.6K
- Earning Date
- ZEPP 11-18-2024
- LVTX 12-10-2024
- Dividend Yield
- ZEPP N/A
- LVTX N/A
- EPS Growth
- ZEPP N/A
- LVTX N/A
- EPS
- ZEPP N/A
- LVTX N/A
- Revenue
- ZEPP $208,946,095.00
- LVTX $7,345,000.00
- Revenue This Year
- ZEPP N/A
- LVTX N/A
- Revenue Next Year
- ZEPP $18.83
- LVTX N/A
- P/E Ratio
- ZEPP N/A
- LVTX N/A
- Revenue Growth
- ZEPP N/A
- LVTX N/A
- 52 Week Low
- ZEPP $2.06
- LVTX $0.96
- 52 Week High
- ZEPP $8.40
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- ZEPP 45.22
- LVTX 32.44
- Support Level
- ZEPP $2.78
- LVTX $0.96
- Resistance Level
- ZEPP $2.94
- LVTX $1.95
- Average True Range (ATR)
- ZEPP 0.18
- LVTX 0.16
- MACD
- ZEPP 0.00
- LVTX -0.05
- Stochastic Oscillator
- ZEPP 17.57
- LVTX 6.55
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in two segments: Xiaomi Wearable Products and Self-branded products & others. The product portfolio includes smartwatches and fitness bands. The majority is from Self-branded products & other segments. It generates majority of the revenue from Xiaomi Wearable Products segment.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.